Related Experiment Video
Updated: Sep 17, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Treatment progress of inherited epidermolysis bullosa
Wen-Ming Wang1, Hao Feng1, Qian-Nan Jia1
1Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Introduction:
Inherited epidermolysis bullosa (EB) is a family of rare-inherited dermatoses that result in mucocutaneous fragility and blister formation inducible by minor trauma. Clinically, EB mainly presents as increased skin fragility with trauma-induced blisters and erosions, combined with extracutaneous manifestations and their complications in other epithelialized organs. No cure for inherited EB is currently available. Treatment of inherited EB is mainly supportive, aiming to reduce patients' pain and itching.
Areas Covered:
Some advances in the treatment of inherited epidermolysis bullosa have recently been achieved, including topical drug treatment, systemic drug treatment, gene-based therapy, and cell-based therapy. This review focuses on the treatment progress of inherited epidermolysis bullosa. PubMed was searched up to February 2025 to identify relevant studies on inherited EB.
Expert Opinion:
Emerging advances of therapies in gene-based therapy and cell-based therapy can partially address the symptoms of EB and provide hope for the patients.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Renewal of Skin Epidermal Stem Cells
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...

